These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37889003)

  • 1. Recombinant outer membrane vesicles delivering eukaryotic expression plasmid of cytokines act as enhanced adjuvants against
    Liu Q; Li B; Lu J; Zhang Y; Shang Y; Li Y; Gong T; Zhang C
    Infect Immun; 2023 Nov; 91(11):e0031323. PubMed ID: 37889003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outer membrane vesicles from genetically engineered
    Liu Q; Shang Y; Shen L; Yu X; Cao Y; Zeng L; Zhang H; Rao Z; Li Y; Tao Z; Liu Z; Huang X
    Virulence; 2024 Dec; 15(1):2367783. PubMed ID: 38937901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outer Membrane Vesicles of
    Song Z; Li B; Zhang Y; Li R; Ruan H; Wu J; Liu Q
    Front Microbiol; 2020; 11():1340. PubMed ID: 32733396
    [No Abstract]   [Full Text] [Related]  

  • 4. Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant.
    Holmgren J; Nordqvist S; Blomquist M; Jeverstam F; Lebens M; Raghavan S
    Vaccine; 2018 Oct; 36(41):6223-6230. PubMed ID: 30119923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally-administered outer-membrane vesicles from Helicobacter pylori reduce H. pylori infection via Th2-biased immune responses in mice.
    Liu Q; Li X; Zhang Y; Song Z; Li R; Ruan H; Huang X
    Pathog Dis; 2019 Jul; 77(5):. PubMed ID: 31504509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
    Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
    Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
    Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN
    Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcomponent vaccine based on CTA1-DD adjuvant with incorporated UreB class II peptides stimulates protective Helicobacter pylori immunity.
    Nedrud JG; Bagheri N; Schön K; Xin W; Bergroth H; Eliasson DG; Lycke NY
    PLoS One; 2013; 8(12):e83321. PubMed ID: 24391754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-expression of Interleukin-17A molecular adjuvant and prophylactic Helicobacter pylori genetic vaccine could cause sterile immunity in Treg suppressed mice.
    Nemattalab M; Shenagari M; Taheri M; Mahjoob M; Nazari Chamaki F; Mojtahedi A; Hasan-Alizadeh E; Ashrafkhani B; Mousavi Niri N
    Cytokine; 2020 Feb; 126():154866. PubMed ID: 31629103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine.
    Gong Y; Tao L; Wang F; Liu W; Jing L; Liu D; Hu S; Xie Y; Zhou N
    Mol Med Rep; 2015 Sep; 12(3):4123-4132. PubMed ID: 26095723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X; Xing Y; Guo L; Lv X; Song H; Xi T
    Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of sncRNA Improves the Protective Efficacy of Outer Membrane Vesicles against Helicobacter pylori Infection in a Mouse Model.
    Li B; Xu Y; Xu T; Guo Z; Xu Q; Li Y; Zeng L; Huang X; Liu Q
    Infect Immun; 2022 Aug; 90(8):e0026722. PubMed ID: 35861532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Helicobacter pylori vaccine research: From candidate antigens to adjuvants-A review.
    Yunle K; Tong W; Jiyang L; Guojun W
    Helicobacter; 2024; 29(1):e13034. PubMed ID: 37971157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody Production and Th1-biased Response Induced by an Epitope Vaccine Composed of Cholera Toxin B Unit and Helicobacter pylori Lpp20 Epitopes.
    Li Y; Chen Z; Ye J; Ning L; Luo J; Zhang L; Jiang Y; Xi Y; Ning Y
    Helicobacter; 2016 Jun; 21(3):234-48. PubMed ID: 26332255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of mucosal immune responses against Helicobacter pylori infection after sublingual and intragastric route of immunization.
    Sjökvist Ottsjö L; Jeverstam F; Yrlid L; Wenzel AU; Walduck AK; Raghavan S
    Immunology; 2017 Feb; 150(2):172-183. PubMed ID: 27676456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
    Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
    Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.
    Zhang HX; Qiu YY; Zhao YH; Liu XT; Liu M; Yu AL
    Mol Cell Probes; 2014 Feb; 28(1):25-30. PubMed ID: 24036137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncated Core/NS3 Fusion Protein of HCV Adjuvanted with Outer Membrane Vesicles of Neisseria meningitidis Serogroup B: Potent Inducer of the Murine Immune System.
    Hekmat S; Sadat SM; Aslani MM; Mahdavi M; Bolhassani A; Asgar Halvaee F; Ghahari SMM; Aghasadeghi MR; Siadat SD
    Iran Biomed J; 2019 Jul; 23(4):235-45. PubMed ID: 30278608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection.
    Liu M; Zhong Y; Chen J; Liu Y; Tang C; Wang X; Zhang Y; Wang P; Logan SM; Chen W; Wei B
    Vaccine; 2020 Mar; 38(14):3031-3041. PubMed ID: 32139315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double mutant heat-labile toxin from Escherichia coli, LT(R192G/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection.
    Sjökvist Ottsjö L; Flach CF; Clements J; Holmgren J; Raghavan S
    Infect Immun; 2013 May; 81(5):1532-40. PubMed ID: 23439305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.